This technology is a method of reshaping the cornea that can be used to correct refractive errors and treat keratoconus.
Keratoconus is a progressive eye disease characterized by thinning and bulging of the cornea into a cone-like shape. This disease causes decreased visual acuity in as many as 1 in 500 people worldwide. Though glasses and contacts can relieve mild cases, invasive surgical methods are ultimately required to strengthen the cornea and prevent disease progression. As such, there remains an unmet need for an effective, non-invasive method of treating keratoconus..
This technology is a non-invasive method to correct vision and treat keratoconus. Using a mechanical load concurrently with standard collagen crosslinking procedures, this technology can reshape the cornea to fix refractive errors. This technique is applicable to any crosslinking methodology, including laser-based, chemical, and UV/riboflavin crosslinking. It can improve the effectiveness of collagen crosslinking and provides a non-invasive alternative to surgical methods of treating keratoconus and other eye disorders.
Patent pending
IR CU20140
Licensing Contact: Sara Gusik